Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A.
Almawi
W Y
WY
Melemedjian
O K
OK
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000502:physiology; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus